GLP‑1 real‑world data for obesity: A new standard for metabolic care
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
Open claims and closed payer claims data are essential for understanding the status and activities...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S. have obesity, representing over 100 million patients.1 Not long ago, bariatric surgery was the only option for substantial weight loss among those with ...